ZTS

Zoetis Inc
NYSEHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC

Key Statistics

Market Cap
$31.48B
P/E Ratio
12.50
EPS
$6.01
Beta
0.75
52W High
$158.55
52W Low
$71.47
50-Day MA
$83.76
200-Day MA
$116.25
Dividend Yield
2.66%
Profit Margin
28.00%
Forward P/E
11.15
PEG Ratio
1.83

About Zoetis Inc

Zoetis Inc. is an American drug company, the world's largest producer of medicine and vaccinations for pets and livestock.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)$9.53B
Gross Profit (TTM)$6.85B
EBITDA$4.07B
Operating Margin36.60%
Return on Equity67.70%
Return on Assets15.50%
Revenue/Share (TTM)$21.81
Book Value$7.84
Price-to-Book9.89
Price-to-Sales (TTM)3.30
EV/Revenue4.121
EV/EBITDA9.67
Quarterly Earnings Growth (YoY)6.00%
Quarterly Revenue Growth (YoY)2.90%
Shares Outstanding$419.23M
Float$418.38M
% Insiders0.15%
% Institutions103.00%

Historical Volatility

HV 10-Day
33.94%
HV 20-Day
34.68%
HV 30-Day
30.46%
HV 60-Day
59.78%
HV Rank
72.6%

Volatility is currently expanding

Analyst Ratings

Consensus ($115.65 target)
3
Strong Buy
8
Buy
9
Hold

Latest News

Bronstein, Gewirtz & Grossman LLC Urges Zoetis Inc. Investors to Act: Class Action Filed Alleging Investor Harm

NEW YORK, July 09, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Zoetis Inc. (NYSE: ZTS) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Zoetis securities between January 14, 2025 and May 6, 2026, both dates inclusive (the “Class Period”).

GlobeNewsWire7/9/2026Neutral
INVESTOR DEADLINE ALERT: Zoetis Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - Contact Kessler Topaz Meltzer & Check, LLP

Did you buy ZTS securities between January 14, 2025, and May 6, 2026 ? Affected ZTS Investor Summary Who: Zoetis Inc. (NYSE: ZTS) What: Securities fraud class action lawsuit filed Class Period: January 14, 2025 through May 6, 2026 Deadline to Seek Lead Plaintiff Status: July 27, 2026 Key Lawsuit Allegations: Material misstatements and/or omissions concerning the company's product adoption.

GlobeNewsWire7/9/2026Neutral
ZTS Investors Have Opportunity to Lead Zoetis Inc. Securities Fraud Lawsuit with the Schall Law Firm

LOS ANGELES, July 09, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Zoetis Inc. (“Zoetis” or “the Company”) (NYSE: ZTS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between January 14, 2025 and May 6, 2026, inclusive (the “Class Period”), are encouraged to contact the firm before July 27, 2026.

GlobeNewsWire7/9/2026Neutral
ZOETIS INC. (ZTS) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Zoetis Inc. Investors of Upcoming Deadline

NEW YORK, July 09, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Zoetis Inc. (“Zoetis” or the “Company”) (NYSE: ZTS) investors of the  July 27, 2026 deadline involving a securities fraud class action lawsuit commenced against the Company. Should You Join The Zoetis Class Action Lawsuit : Do you, or did you, own shares of Zoetis Inc. (NYSE: ZTS)?

GlobeNewsWire7/9/2026Neutral
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Zoetis Inc. of Class Action Lawsuit and Upcoming Deadlines – ZTS

NEW YORK, July 07, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Zoetis Inc. (“Zoetis” or the “Company”) (NYSE: ZTS). Such investors are advised to contact Danielle Peyton at  newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

GlobeNewsWire7/7/2026Neutral
ZTS DEADLINE NOTICE: ROSEN, A LEADING AND RANKED FIRM, Encourages Zoetis Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – ZTS

NEW YORK, July 07, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Zoetis Inc. (NYSE: ZTS) between January 14, 2025 and May 6, 2026, inclusive (the “Class Period”), of the important July 27, 2026 lead plaintiff deadline.

GlobeNewsWire7/7/2026Neutral
Zoetis Inc. (ZTS) Class Action Lawsuit Seeks Recovery for Investors; July 27, 2026, Deadline - Contact Kessler Topaz Meltzer & Check, LLP

Did you buy ZTS securities between January 14, 2025, and May 6, 2026? Affected ZTS Investor Summary Who: Zoetis Inc. (NYSE: ZTS) What: Securities fraud class action lawsuit filed Class Period: January 14, 2025 through May 6, 2026 Deadline to Seek Lead Plaintiff Status: July 27, 2026 Key Lawsuit Allegations: Material misstatements and/or omissions concerning the company's product adoption.

PRNewsWire7/7/2026Neutral

More HEALTHCARE Stocks

Data last updated: 7/9/2026